Australian Barrett's Cohort With Dysplasia and Early Cancer Study
NCT02198976 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2025-03-27
Summary
The purpose of this study is to collect prospective observational data regarding endoscopic management and outcomes of patients with Barrett's oesophagus (BO) with high grade dysplasia and/or intramucosal carcinoma. To observe the natural history of patients with low grade dysplastic and non dysplastic Barrett's oesophagus
Conditions
- Barrett's Esophagus
Sponsors & Collaborators
-
Professor Michael Bourke
lead OTHER
Principal Investigators
-
Michael J Bourke, MBBS · Western Sydney Local Health District
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2034-05-31
- Completion
- 2034-11-30
Countries
- Australia
Study Locations
More Related Trials
-
Barretts oEsophageal Resection With Steroid Therapy Trial
NCT02004782 ·Status: WITHDRAWN ·Phase: PHASE4
-
Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers
NCT05688176 ·Status: RECRUITING
-
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
NCT01124214 ·Status: COMPLETED ·Phase: NA
-
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
NCT04293458 ·Status: COMPLETED ·Phase: NA
-
Barrett's Esophagus Patient Registry
NCT01776346 ·Status: UNKNOWN
-
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
NCT04295811 ·Status: UNKNOWN ·Phase: NA
-
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
NCT02075905 ·Status: COMPLETED
-
Early Detection of Barrett's Esophagus
NCT00081354 ·Status: COMPLETED
-
Microbiome Involvement With Barrett's Esophagus and Progression to Esophageal Adenocarcinoma
NCT03216135 ·Status: UNKNOWN
-
Epidemiology of Barrett's Esophagus: A Population Based Study
NCT01286155 ·Status: COMPLETED
-
Enhancing Screening Practices for BE
NCT07335445 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma
NCT07212491 ·Status: ENROLLING_BY_INVITATION
-
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
NCT06381583 ·Status: COMPLETED
-
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
NCT02560623 ·Status: COMPLETED ·Phase: NA
-
The Effect of Ablation Therapy on Barrett's Esophagus
NCT00587314 ·Status: ENROLLING_BY_INVITATION
-
Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease
NCT02890979 ·Status: COMPLETED ·Phase: NA
-
The Study of Barrett's Esophagus: What Are the Factors of Progression
NCT00586404 ·Status: TERMINATED
-
University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository
NCT02427269 ·Status: ENROLLING_BY_INVITATION
-
WavSTAT® Optical Biopsy System to Target Esophageal Biopsies
NCT00747136 ·Status: TERMINATED
-
Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus
NCT04316975 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Therapy of Early Cancer in Barretts Esophagus
NCT00217087 ·Status: COMPLETED ·Phase: PHASE2
-
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus
NCT00431756 ·Status: ACTIVE_NOT_RECRUITING
-
Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas
NCT05745857 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia
NCT02464930 ·Status: UNKNOWN
-
Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer
NCT00220077 ·Status: UNKNOWN ·Phase: NA